BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21846801)

  • 1. The hinge region of the TSH receptor stabilizes ligand binding and determines different signaling profiles of human and bovine TSH.
    Jaeschke H; Schaarschmidt J; Günther R; Mueller S
    Endocrinology; 2011 Oct; 152(10):3986-96. PubMed ID: 21846801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the hinge region and its adjacent domains on binding and signaling patterns of the thyrotropin and follitropin receptor.
    Schaarschmidt J; Huth S; Meier R; Paschke R; Jaeschke H
    PLoS One; 2014; 9(10):e111570. PubMed ID: 25340405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The superagonistic activity of bovine thyroid-stimulating hormone (TSH) and the human TR1401 TSH analog is determined by specific amino acids in the hinge region of the human TSH receptor.
    Mueller S; Kleinau G; Szkudlinski MW; Jaeschke H; Krause G; Paschke R
    J Biol Chem; 2009 Jun; 284(24):16317-16324. PubMed ID: 19386596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel TSH interaction sites by systematic binding analysis of the TSHR hinge region.
    Mueller S; Szkudlinski MW; Schaarschmidt J; Günther R; Paschke R; Jaeschke H
    Endocrinology; 2011 Aug; 152(8):3268-78. PubMed ID: 21628383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling.
    Alvarez CA; Narayan P; Huang J; Puett D
    Endocrinology; 1999 Apr; 140(4):1775-82. PubMed ID: 10098515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin stimulation of the lutropin/choriogonadotropin receptor: different sites mediate agonist activity and high affinity binding.
    Hidaka A; Ban T; Panesar NS; Minegishi T; Kohn LD; Tahara K
    Thyroid; 1994; 4(4):447-57. PubMed ID: 7711510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended hormone binding site of the human thyroid stimulating hormone receptor: distinctive acidic residues in the hinge region are involved in bovine thyroid stimulating hormone binding and receptor activation.
    Mueller S; Kleinau G; Jaeschke H; Paschke R; Krause G
    J Biol Chem; 2008 Jun; 283(26):18048-55. PubMed ID: 18441013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms.
    Kleinau G; Krause G
    Endocr Rev; 2009 Apr; 30(2):133-51. PubMed ID: 19176466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A free carboxylate oxygen in the side chain of position 674 in transmembrane domain 7 is necessary for TSH receptor activation.
    Neumann S; Krause G; Chey S; Paschke R
    Mol Endocrinol; 2001 Aug; 15(8):1294-305. PubMed ID: 11463854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras homolog enriched in striatum inhibits the functional activity of wild type thyrotropin, follicle-stimulating hormone, luteinizing hormone receptors and activating thyrotropin receptor mutations by altering their expression in COS-7 cells.
    Agretti P; De Marco G; Pinchera A; Vitti P; Bernal J; Tonacchera M
    J Endocrinol Invest; 2007 Apr; 30(4):279-84. PubMed ID: 17556863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation.
    Neumann S; Claus M; Paschke R
    Eur J Endocrinol; 2005 Apr; 152(4):625-34. PubMed ID: 15817920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action.
    Wonerow P; Neumann S; Gudermann T; Paschke R
    J Mol Med (Berl); 2001 Dec; 79(12):707-21. PubMed ID: 11862314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on homologous desensitization of the thyrotropin receptor in 293 human embryonal kidney cells.
    Nagayama Y; Chazenbalk GD; Takeshita A; Kimura H; Ashizawa K; Yokoyama N; Rapoport B; Nagataki S
    Endocrinology; 1994 Sep; 135(3):1060-5. PubMed ID: 8070347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The middle portion in the second cytoplasmic loop of the thyrotropin receptor plays a crucial role in adenylate cyclase activation.
    Kosugi S; Kohn LD; Akamizu T; Mori T
    Mol Endocrinol; 1994 Apr; 8(4):498-509. PubMed ID: 7914349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FSH and TSH binding to their respective receptors: similarities, differences and implication for glycoprotein hormone specificity.
    Núñez Miguel R; Sanders J; Chirgadze DY; Blundell TL; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2008 Sep; 41(3):145-64. PubMed ID: 18606720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
    Castro I; Lima L; Seoane R; Lado-Abeal J
    Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction.
    Mizutori Y; Chen CR; McLachlan SM; Rapoport B
    Mol Endocrinol; 2008 May; 22(5):1171-82. PubMed ID: 18218728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
    Neumann S; Krohn K; Chey S; Paschke R
    Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.